🇺🇸 FDA
Patent

US 10507211

Treatment for hereditary neuropathy with liability to pressure palsies (HNPP)

granted A61KA61K31/519

Quick answer

US patent 10507211 (Treatment for hereditary neuropathy with liability to pressure palsies (HNPP)) held by THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Grant date
Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/519